                         SEQUENCE LISTING

<110>  SHATTUCK LABS, INC.
 
<120>  METHOD OF DETERMINING RESISTANCE TO CHECKPOINT INHIBITOR 
       THERAPIES

<130>  SHK-038PC1/116981-5038

<150>  US 63/121083
<151>  2020-12-03

<150>  US 63/173090
<151>  2021-04-09

<150>  US 63/215735
<151>  2021-06-28

<150>  US 63/276066
<151>  2021-11-05

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  1

Met Ala Ala Val Gly Pro Arg Thr Gly Pro Gly Thr Gly Ala Glu Ala 
1               5                   10                  15      


Leu Ala Leu Ala Ala Glu Leu 
            20              


<210>  2
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  2

Ala Ala Thr Arg Ala Pro Pro Phe Pro Leu Pro Cys Pro 
1               5                   10              


<210>  3
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  3

His Gly Ser Gln Ala Ala Ala Ala Arg Ala Ala Ala Ala Arg Cys Gly 
1               5                   10                  15      


<210>  4
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  4

Asn Val Ser Leu Lys Thr Phe Val Leu Lys Gly Met Leu Lys Lys Phe 
1               5                   10                  15      


Lys Glu Asp Leu Arg Gly Glu Leu Glu Lys Glu Glu Lys Val 
            20                  25                  30  


